MEET THE TEAM

Dr Shahzad Malik

Dr Shahzad Malik

Chairman

Shahzad is a General Partner at Advent Life Sciences, a leading trans-Atlantic venture investor focused on building innovative Life Sciences businesses in the UK, Europe and the USA. He joined Advent in 1999 with a strong background in science, clinical medicine, and international finance.

After gaining an MA in Physiological Sciences from Oxford University and an MD from Cambridge University, he specialised in interventional cardiology while also pursuing clinical and fundamental scientific research in heart muscle disorders.

Since joining Advent, Shahzad has been actively involved in over 25 portfolio companies in Europe and the USA in all sectors of Life Sciences, including Algeta, Respivert, Biocartis and Axonics Modulation Technologies. Shahzad currently serves on the Board of several portfolio Companies, including Acutus Medical, GMP-Orphan, Nalu Medical and Curve Therapeutics.